Penn Medical Ethics and Health Policy

Hybrid! BRB 0253 and via Zoom

Penn Bioethics Seminar (PBS): Experience as Epistemology in Muslim Medical Decision Making with Zahra Ayubi, PhD

Learn More 2023-05-30 12:00:00 2023-05-30 13:00:00 America/New_York Penn Bioethics Seminar (PBS): Experience as Epistemology in Muslim Medical Decision Making with Zahra Ayubi, PhD Experience as Epistemology in Muslim Medical Decision Making Zahra Ayubi, PhD Associate Professor of Religion, Dartmouth College Lunch is provided for in-person attendees. Livestreaming available via Zoom. Zahra Ayubi, PhD , President - Society for the Study of Muslim Ethics, Associate Professor at Dartmouth College and author of Gendered Morality. In this talk, I present ethnographic narratives of American Muslim women that deal with medical racism as well as patriarchal Islamic jurisprudential opinions (fatwas) on matters of reproductive health. I argue that ethical medical care of Muslim women requires centering their experiences and developing both religion and gender conscientious approaches. Hybrid! BRB 0253 and via Zoom Penn Medical Ethics

June

6

Virtual via Zoom

Penn Bioethics Seminar (PBS): Ableism in Biomedical Research with Maya Sabatello, LLB, PhD

Learn More

June

13

Hybrid! 1402 Blockley Hall, 423 Guardian Drive and via Zoom

Penn Bioethics Seminar (PBS): Behavioral Interventions to Promote Adherence to Guidelines with Catherine Pollak, PhD

Learn More 2023-06-13 12:00:00 2023-06-13 13:00:00 America/New_York Penn Bioethics Seminar (PBS): Behavioral Interventions to Promote Adherence to Guidelines with Catherine Pollak, PhD Behavioral Interventions to Promote Adherence to Guidelines Catherine Pollak, PhD Harkness Fellow in Health Care Policy and Practice, MEHP, PSOM Lunch is provided for in-person attendees. Livestreaming available via Zoom. Catherine Pollak, PhD, is a senior economist at the Direction for Statistics, Research and Evaluation at the Ministry of Health in France. She is currently a 2022/23 Harkness Fellow in Policy and Practice of The Commonwealth Fund, based at NYU Grossman School of Medicine and CHIBE University of Pennsylvania. This presentation will discuss two ongoing randomized controlled trials that use behavioral insights to promote adherence to clinical guidelines. Hybrid! 1402 Blockley Hall, 423 Guardian Drive and via Zoom Penn Medical Ethics

June

14

RCH B102AB, Richards Building, 3700 Hamilton Walk

Research Ethics and Policy Series (REPS): The Burden of Uncertainty: Raising Regulatory Standards to Improve Health Equity with Reshma Ramachandran, MD, MPP, MHS

Learn More 2023-06-14 12:00:00 2023-06-14 13:00:00 America/New_York Research Ethics and Policy Series (REPS): The Burden of Uncertainty: Raising Regulatory Standards to Improve Health Equity with Reshma Ramachandran, MD, MPP, MHS The Burden of Uncertainty: Raising Regulatory Standards to Improve Health Equity Reshma Ramachandran, MD, MPP, MHS Assistant Professor of Medicine (General Medicine), School of Medicine, Yale University Co-sponsored by the Department of Family Medicine and Community Health at the Perelman School of Medicine Lunch is provided for in-person attendees. Livestreaming available via Zoom. Reshma Ramachandran, MD, MPP, MHS is a board-certified family physician and health services researcher. Her research focuses on the realignment of incentives for healthcare stakeholders including pharmaceutical companies, hospitals, and universities towards prioritizing equitable patient access to safe, effective health technologies. Recently, the U.S. Food and Drug Administration (FDA) has been placing greater emphasis and implementing reforms focused on improving health equity. The focus of the reforms has been largely on increasing representation in clinical trials, enhancing transparency and access to available data on the effect of medical products on minority populations, and promoting health and safety communication to these populations. Concurrently, FDA continues to increasingly adopt regulatory flexibility in their review process, accepting less rigorous evidence as the basis of approval of novel medical products. In the case of accelerated approval, the agency allows for residual uncertainty at the time of approval, but then requires sponsors to complete additional studies that confirm clinical benefit in a timely manner; should these not be completed or if the studies yield negative results, FDA can withdraw these drugs from the market. However, the expanded and more flexible use of this pathway by the FDA has raised questions about which communities will bear the burden of such uncertainty and whether this may in fact exacerbate health disparities. In this presentation, Dr. Ramachandran will discuss trends in FDA’s adoption of regulatory flexibility in the approval of novel medical predicts, the implication of such policies, and proposals to center health equity in regulatory decision-making. RCH B102AB, Richards Building, 3700 Hamilton Walk Penn Medical Ethics

June

20

Virtual via Zoom

Penn Bioethics Seminar (PBS): Policy Supports for Formal and Family Caregivers

Learn More

December

13

RCH B102AB, Richards Building, 3700 Hamilton Walk

Bronstein Lecture: TBA with Sheila Varadan

Learn More